$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Effect of Reducing Inflammation of Coptis chinensis Extract -Ceramide Complex through ECS Control in Atopic Dermatitis 원문보기

Journal of Korean Medicine = 대한한의학회지, v.42 no.4, 2021년, pp.197 - 207  

Ahn, Sang Hyun (Department of Anatomy, College of Korean Medicine, Semyung University) ,  Kim, Ki Bong (Department of Korean Pediatrics, Pusan National University Korean Hospital)

Abstract AI-Helper 아이콘AI-Helper

Objectives: The purpose of this study was to confirm effect of reducing inflammation of Coptis chinensis extract-ceramide complex through the endocannabinoid system (ECS) control in atopic dermatitis. Methods: 8-week-old ICR mice were divided into normal group (Ctrl), lipid barrier elimination group...

주제어

표/그림 (3)

참고문헌 (31)

  1. Kim, J.H., (2004). Current understanding of atopic dermatitis. Pediatr Allergy Respir Dis, 14(1), 12-23. 

  2. Blume-Peytavi, U., & Metz, M. (2012). Atopic dermatitis in children: management of pruritus. J Eur Acad Dermatol Venereol, 26, 2-8. https://doi.org/10.1111/j.1468-3083.2012.04710.x 

  3. Lee, J.Y., & Kim, D.G. (1999). The Clinical Study of Atopic Dermatitis. J Pediatr Korean Med, 13(2), 171-86. 

  4. Jee, H.M., Kim, K.W., Kim, C.S., Sohn, M.H., Shin, D.C., & Kim, K.E. (2009). Prevalence of asthma, rhinitis and eczema in Korean children using the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaires. Pediatr Allergy Respir Dis, 19(2), 165-72. 

  5. Kim, B.E., & Leung, D. (2012). Epidermal barrier in atopic dermatitis. Immunol Res, 4(1), 12-6. http://dx.doi.org/10.4168/aair.2012.4.1.12 

  6. Hogan, M.B., Peele, K., & Wilson, N.W. (2012). Skin barrier function and its importance at the start of the atopic march. J Allergy, 901940 . https://doi.org/10.1155/2012/901940 

  7. Ahn, K.M., Kim, J.H., Kwon, H.J., Chae, Y.M., Hahm, M.I., Lee, K.J., et al. (2011). The prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in Korean children: nationwide cross-sectional survey using complex sampling design. J Korean Med Assoc, 54(7), 769-78. https://doi.org/10.5124/jkma.2011.54.7.769 

  8. Kim, M.J., & Lee, S.Y. (2000). A Literature Study of Atopic Dermatitis for Children. J Pediatr Korean Med, 14(2), 167-82. 

  9. Muluye, R.A., Bian, Y., & Alemu, P.N. (2014). Anti-inflammatory and antimicrobial effects of heat-clearing Chinese herbs: a current review. J Tradit Complement Med, 4(2), 93-8. https://doi.org/10.4103/2225-4110.126635 

  10. Chin, L.W., Cheng, Y.W., Lin, S.S., Lai, Y.Y., Lin, L.Y., Chou, M.Y., et al. (2010). Anti-herpes simplex virus effects of berberine from Coptidis Rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San. Arch Virol, 155(12), 1933-41. https://doi.org/10.1007/s00705-010-0779-9 

  11. Yu, Y.E., Park, E.Y., Jung, D.H., Byun, S.H., Kim, S.C., & Park, S.M. (2010). Antibacterial activity of oriental medicinal herb extracts against skin pathogens. J Life Sci, 20(7), 1143-50. https://doi.org/10.5352/JLS.2010.20.7.1143 

  12. Kim, H.K., & Hong, S.U. (2011). The anti-inflammatory effects of Huang-Lyun (Coptidis Rhizoma, CR) on injured tissue after burn elicitation. J Korean Oriental Med, 32(2), 1-13. 

  13. Baron, E.D., Barzilai, D., Johnston, G., Kawashima, M., Takigawa, M., Nakagawa, H., et al. (2002). Stevens SR. Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K. Br J Dermatol, 147, 710-5. https://doi.org/10.1046/j.1365-2133.2002.04895.x 

  14. Salzet, M. (2000). Invertebrate molecular neuroimmune processes. Brain Res Rev, 34(1), 69-79. https://doi.org/10.1016/S0165-0173(00)00041-2 

  15. Pacher, P., Batkai, S., & Kunos, G. (2006). The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev, 58(3), 389-462. https://doi.org/10.1124/pr.58.3.2 

  16. Kupczyk, P., Reich, A., & Szepietowski, J.C. (2009). Cannabinoid system in the skin - a possible target for future therapies in dermatology. Exp Dermatol, 18(8), 669-79. https://doi.org/10.1111/j.1600-0625.2009.00923.x 

  17. Miller, L.K., & Devi, L.A. (2011). The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications. Pharmacol Rev, 63(3), 461-70. https://doi.org/10.1124/pr.110.003491 

  18. Luger, T.A. (2002). Neuromediators--a crucial component of the skin immune system. J Dermatol Sci, 30(2), 87-93. https://doi.org/10.1016/S0923-1811(02)00103-2 

  19. Maccarrone, M., Rienzo, M., Battista, N., Gasperi, V., Guerrieri, P., Rossi, A., et al. (2003). The Endocannabinoid System in Human Keratinocytes: Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem, 278(36), 33896-903. https://doi.org/10.1074/jbc.M303994200 

  20. Karsak, M., Gaffal, E., Date, R., Wang-Eckhardt, L., Rehnelt, J., & Petrosino, S. (2007). Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System. Science, 316(5830), 1494-97. https://doi.org/10.1126/science.1142265 

  21. Casanova, M.L., Blazquez, C., Martinez-Palacio, J., Villanueva, C., Fernandez-Acenero, M.J., Huffman, J.W., et al. (2003). Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest, 111(1), 43-50. https://doi.org/10.1172/JCI16116. 

  22. Walker, J.M., & Hohmann, A.G. (2005). Cannabinoid mechanisms of pain suppression. Handb Exp Pharmacol, 168, 509-54. https://doi.org/10.1007/3-540-26573-2_17 

  23. Jhaveri, M.D., Richardson, D., & Chapman, V. (2007). Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain. Br J Pharmacol, 152(5), 624-32. https://dx.doi.org/10.1038%2Fsj.bjp.0707433 

  24. Toth, B.I., Dobrosi, N., Dajnoki, A., Czifra, G., Olah, A., Szollosi, A.G., et al. (2011). Endocannabinoids Modulate Human Epidermal Keratinocyte Proliferation and Survival via the Sequential Engagement of Cannabinoid Receptor-1 and Transient Receptor Potential Vanilloid-1. J Invest Dermatol, 131(5), 1095-104. https://doi.org/10.1038/jid.2010.421 

  25. Toth, K.F., Adam, D., Biro, T., & Olah, A. (2019). Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System. Molecules, 24(5), 918. https://doi.org/10.3390/molecules24050918 

  26. Arbabi, S., & Maier, R.V. (2002). Mitogen-activated protein kinases. Crit Care Med, 30(1), 74-9. 

  27. Chung, H.Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., Seo, A.Y., et al. (2009). Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev, 8(1), 18-30. https://doi.org/10.1016/j.arr.2008.07.002 

  28. Baeuerle, P.A., & Baltimore, D. (1996). NF-kappa B: ten years after. Cell, 87(1), 13-20. https://doi.org/10.1016/s0092-8674(00)81318-5 

  29. Aktan, F. (2004). iNOS-mediated nitric oxide production and its regulation. Life Sciences, 75(6), 639-53. https://doi.org/10.1016/j.lfs.2003.10.042 

  30. Kay, A.B.(2001). Allergy and allergic diseases. First of two parts. N Engl J Med, 344, 30-7. https://doi.org/10.1056/nejm200101043440106 

  31. Jo, J.W., & Kim, C.Y. (2017). The Neurotransmitter Pathway of Itching. J Life Sci, 27(5), 600-10. https://doi.org/10.5352/JLS.2017 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로